TMCnet News
Lyric and Concert Expand Partnership to Deliver Laboratory Payment Accuracy SolutionThe Diagnostics Module—available through Lyric's expanded partnership with Concert—will seamlessly deliver Concert's integrated policy and payment accuracy capabilities for a growing scope of laboratory testing PHILADELPHIA, May 1, 2024 /PRNewswire/ -- Lyric, an AI-first leader in payment accuracy, has expanded its partnership with Concert to deliver payment accuracy across a rapidly expanding set of advanced and routine laboratory tests, the companies announced today. The Diagnostics Module, formerly known as the Genetic Testing Module, will expand to address outpatient infectious disease testing, which has become the largest area of outpatient lab spend for many health plans, due to the increases in testing during the COVID-19 pandemic. Together, Concert and Lyric will deliver a technology solution for laboratory payment accuracy that is transparent, reduces the chance for errors, and is minimally abrasive. "Managing the growth and complexity of laboratory testing is a top priority for many of our health plan customers," said Lyric CEO Rajeev Ronanki. "Combining Lyri's market-leading payment accuracy capabilities with Concert's data, clinical policies, and AI-powered edits will deliver unparalleled accuracy for our customers and aligns with our strategy to bring best-in-class partner solutions to customers via Lyric's technology." The solution will deliver Concert's claim editing—based on its integrated payment policy and medical policy content—through a seamless customer experience. The companies expect to continue to expand this solution to a broadening set of laboratory testing, delivering a level of transparency and accuracy not available from others on the market. "Concert is rapidly deploying solutions to enable transparency, efficiency, and value in precision health services, including diagnostics and therapeutics," said Concert CEO Rob Metcalf. "Partnering with Lyric makes these solutions available to customers where they want them, in a solution they use and trust, with minimal implementation and maintenance effort required. The ultimate beneficiary is the health consumer who can access precision healthcare at lower costs." Lyric and Concert first partnered in 2023 to deliver an integrated genetic test management solution. The expanded Diagnostics Module is expected to be available to customers in summer 2024. About Lyric: About Concert Amy Churchill View original content to download multimedia:https://www.prnewswire.com/news-releases/lyric-and-concert-expand-partnership-to-deliver-laboratory-payment-accuracy-solution-302133463.html SOURCE Lyric |